The Board and the Chair of the Vaccination Group identified the necessary fields of expertise. An ad hoc working group was set up which included experts in tropical medicine, infectiology, epidemiology and travel medicine. The experts of this working group provided a general and an ad hoc declaration of interests and the Committee on Deontology assessed the potential risk of conflicts of interest.

This advisory report is based on a review of the scientific literature published in both scientific journals and reports from national and international organisations competent in this field (peerreviewed and non-peer-reviewed), as well as on the opinion of the experts. Information and data used in the report were mainly extracted from EPAR and the ACIP meeting of February 2023.

  • EMA: https://www.ema.europa.eu/en/documents/product-information/qdenga-eparproduct-information_en.pdf
  • EMA: https://www.ema.europa.eu/documents/assessment-report/qdenga-eparpublic-assessment-report_en.pdf
  • ACIP: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-02/slides02-23/Dengue-03-Paz-Bailey-508.pdf

Once the advisory report was approved by the ad hoc working group and Belgian NITAG, it was ultimately validated by the Board of the SHC.

  • Recommendation
  • Europe
  • Belgium
  • Dengue